| 2021 Jan 19 |
Science Daily |
Study identifies a nonhuman primate model that mimics severe COVID-19 similar to humans |
Aged, wild-caught African green monkeys exposed to the SARS-CoV-2 virus developed acute respiratory distress syndrome (ARDS) with clinical symptoms similar to those observed in the most serious human cases of COVID-19, report researchers in The American Journal of Pathology, published by Elsevier. This is the first study to show that African green monkeys can develop severe clinical disease after SARS-CoV-2 infection, suggesting that they may be useful models for the study of COVID-19 in humans. |
The American Journal of Pathology |
Acute Respiratory Distress in Aged, SARS-CoV-2–Infected African Green Monkeys but Not Rhesus Macaques. ( Nov 7, 2020) |
Robert V. Blair |
Tulane National Primate Research Center, |
5 |
Animal Model studies |
| 2021 Apr 12 |
The scientist |
Seizures Common in Hospitalized COVID-19 Patients |
About 10 percent of COVID-19 patients who experienced cognitive symptoms and who were hospitalized during the early days of the pandemic experienced nonconvulsive seizures. |
Annals of Neurology |
Electroencephalographic abnormalities are common in COVID-19 and are associated with outcomes. |
L. Lin,shafi MM |
|
5 |
clinical management |
| 2021 May 04 |
Science Daily |
People with disabilities faced pandemic triage biases |
|
Disaster Medicine and Public Health Preparedness |
Discrimination and Bias in State Triage Protocols Towards Populations with Intellectual Disabilities During the COVID-19 Pandemic. |
Ashley Brooke Felt, Dionne Mitcham, Morgan Hathcock, Raymond Swienton, Curtis Harris |
University of Georgia. |
4 |
clinical management |
| 2020 Oct 20 |
BioSpectrum |
IIT Kgp commercialises COVID-19 diagnostic device COVIRAP |
A new low-cost Covid-19 diagnostic method named COVIRAP, developed by the Indian Institute of Technology (IIT), Kharagpur. |
|
|
Professor Suman Chakraborty, Dr. Arindam Mondal |
IIT, Kharagpur |
5 |
Diagnostics |
| 2021 Apr 21 |
The Hindu |
Global Launch of COVIRAP – Nucleic acid-based Point-of-Care Diagnostic Device for COVID-19 and beyond.IIT Kharagpur launches COVIRAP diagnostic technology |
Global Launch of COVIRAP – Nucleic acid-based Point-of-Care Diagnostic Device for COVID-19 and beyond. generic step-wise isothermal nucleic acid-based testing technology for the rapid diagnostics of pathogenic infections including but not limited to SARS-CoV-2 in individuals.Nasal Swab/ Saliva to result from integration in about 45 minutes in a highly affordable pre-programmable portable device developed by the team, without requiring any separate facility for RNA extraction.ead researchers Professor Suman Chakraborty, Dr. Arindam Mondal and their research group has been licensed for commercialization to the Rapid Diagnostic Group of Companies, India and Bramerton Holdings LLC, USA |
|
|
Professor Suman Chakraborty, Dr. Arindam Mondal |
IIT, Kharagpur |
5 |
Diagnostics |
| 2020 Dec 07 |
Science Daily |
Paper-based electrochemical sensor can detect COVID-19 in less than five minutes |
Reported a rapid, ultrasensitive test using a paper-based electrochemical sensor to detect the presence of the virus in less than five minutes. |
ACS Nano |
Rapid, Ultrasensitive, and Quantitative Detection of SARS-CoV-2 Using Antisense Oligonucleotides Directed Electrochemical Biosensor Chip. |
Maha Alafeef, Ketan Dighe, Parikshit Moitra, Dipanjan Pan. |
University of Illinois Grainger College of Engineering |
5 |
Diagnostics |
| 2021 May 12 |
Science Daily |
Rapid COVID-19 diagnostic test delivers results within 4 minutes with 90 percent accuracy |
This study reports a rapid and inexpensive diagnostic test, called RAPID 1.0 (Real-time Accurate Portable Impedimetric Detection prototype 1.0) which provides a result within 4 minutes. The RAPID technology is based on electrochemical impedance spectroscopy (EIS), which transforms the binding event between the SARS-CoV-2 spike protein and receptor protein ACE2 into a detected electrical signal. The signal can be read through a desktop instrument or a smartphone. |
Matter |
Low-cost Biosensor for Rapid Detection of SARS-CoV-2 at the Point-of-Care |
Marcelo D.T. Torres, William R. de Araujo, Lucas F. de Lima, Andre L. Ferreira, Cesar de la Fuente-Nunez. |
University of Pennsylvania School of Medicine. |
5 |
Diagnostics |
| 2021 May 12 |
Science Daily |
Artificial intelligence tool uses chest X-ray to differentiate worst cases of COVID-19 |
In this study, researchers developed an artificial-intelligence-based effective tool that analyzes patients' chest X-ray patterns and quickly identifies COVID-19 patients' severity. |
npj Digital Medicine |
An artificial intelligence system for predicting the deterioration of COVID-19 patients in the emergency department. |
Farah E. Shamout, Yiqiu Shen, Nan Wu, Aakash Kaku, Jungkyu Park, Taro Makino, Stanisław Jastrzębski, Jan Witowski, Duo Wang, Ben Zhang, Siddhant Dogra, Meng Cao, Narges Razavian, David Kudlowitz, Lea Azour, William Moore, Yvonne W. Lui, Yindalon Aphinyanaphongs, Carlos Fernandez-Granda, Krzysztof J. Geras. |
NYU Langone Health / NYU Grossman School of Medicine |
5 |
Diagnostics |
| 2021 May 11 |
Science Daily |
In the blood: Which antibodies best neutralize the coronavirus in COVID-19 patients? |
|
The Journal of Immunology |
Comparative Analysis of Antigen-Specific Anti–SARS-CoV-2 Antibody Isotypes in COVID-19 Patients |
Hidetsugu Fujigaki, Masato Inaba, Michiko Osawa, Saya Moriyama, Yoshimasa Takahashi, Tadaki Suzuki, Kenya Yamase, Yukihiro Yoshida, Yo Yagura, Takayoshi Oyamada, Masao Takemura, Yohei Doi, Kuniaki Saito |
Fujita Health University |
5 |
Diagnostics |
| 2021 May 11 |
Science Daily |
COVID-19 wastewater testing proves effective in new study |
In this study, researchers have developed a protocol to detect COVID-19 in wastewater. The technique proved better at detecting initial infections. Thus, wastewater testing is potential method for detecting and controlling COVID-19 in places where people live in close quarters. |
Applied and Environmental Microbiology |
Development of wastewater pooled surveillance of SARS-CoV-2 from congregate living settings. |
Lisa M. Colosi, Katie E. Barry, Shireen M. Kotay, Michael D. Porter, Melinda D. Poulter, Cameron Ratliff, William Simmons, Limor I. Steinberg, D. Derek Wilson, Rena Morse, Paul Zmick, Amy J. Mathers. |
University of Virginia Health System |
5 |
Diagnostics |
| 2021 May 03 |
Science Daily |
Human organ chips enable COVID-19 drug repurposing |
An antimalarial drug, amodiaquine, was found highly effective against SARS-CoV-2 at preventing viral entry. The study was validated, in cultured cells and a small animal model of COVID-19, using infectious SARS-CoV-2 virus. |
Nature Biomedical Engineering |
A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics. |
Longlong Si, Haiqing Bai, Melissa Rodas, Wuji Cao, Crystal Yuri Oh, Amanda Jiang, Rasmus Moller, Daisy Hoagland, Kohei Oishi, Shu Horiuchi, Skyler Uhl, Daniel Blanco-Melo, Randy A. Albrecht, Wen-Chun Liu, Tristan Jordan, Benjamin E. Nilsson-Payant, Ilona Golynker, Justin Frere, James Logue, Robert Haupt, Marisa McGrath, Stuart Weston, Tian Zhang, Roberto Plebani, Mercy Soong, Atiq Nurani, Seong Min Kim, Danni Y. Zhu, Kambez H. Benam, Girija Goyal, Sarah E. Gilpin, Rachelle Prantil-Baun, Steven P. Gygi, Rani K. Powers, Kenneth E. Carlson, Matthew Frieman, Benjamin R. tenOever, Donald E. Ingber. |
Wyss Institute for Biologically Inspired Engineering at Harvard |
5 |
Drug in vitro study |
| 2021 May 06 |
News Medical |
Indian SARS-CoV-2 variant shows enhanced host cell entry and immune evasion |
|
Biorxiv |
SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination (https://doi.org/10.1101/2021.05.04.442663) |
Markus Hoffmann, Heike Hofmann-Winkler, et al., |
the University of Gottingen Medical Center, the Friedrich-Alexander University of Erlangen-Nurnberg and Hannover Medical School |
5 |
Drug in vitro study, Immunology, Molecular interaction |
| 2021 Apr 20 |
The hindu |
Oral drug Molnupiravir effective against COVID-19 in hamsters: study |
The oral drug Molnupiravir administered to hamster showed an significant decrease in coronavirus level. |
Nature Communications |
Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model |
National Institutes of Health (NIH) in the U.S. and the University of Plymouth |
National Institutes of Health (NIH) in the U.S. and the University of Plymouth |
5 |
Drugs animal studies |
| 2021 Apr 22 |
Science Daily |
Among COVID-19 survivors, an increased risk of death, serious illness |
In the study, researchers revealed that COVID-19 survivors had faced several long health problems and an increased risk of death after surviving the initial infection. They identified the major health issues that persisted in COVID-19 patients over at least six months of period. |
Nature |
High-dimensional characterization of post-acute sequalae of COVID-19. |
Ziyad Al-Aly, Yan Xie, Benjamin Bowe |
Washington University School of Medicine |
5 |
Epidemiology |
| 2021 Apr 29 |
Science Daily |
Low risk of infection in babies born to mothers with COVID-19, study finds |
The population-based study showed that babies born to corona-positive mothers more likely to be born early, and only a few were infected with COVID-19. Of 2,323 babies born to SARS-CoV-2 positive mothers, one-third were tested close to or just after childbirth. Only 21 babies of these women tested positive for the virus at some point during the first 28 days. |
JAMA |
Association of Maternal SARS-CoV-2 Infection in Pregnancy With Neonatal Outcomes. |
Mikael Norman, Lars Naver, Jonas Soderling, Mia Ahlberg, Helena Hervius Askling, Bernice Aronsson, Emma Bystrom, Jerker Jonsson, Verena Sengpiel, Jonas F. Ludvigsson, Stellan Hakansson, Olof Stephansson. |
Karolinska Institutet |
4 |
Epidemiology |
| 2021 Apr 29 |
Science Daily |
Many Hispanics died of COVID-19 because of work exposure, study suggests |
|
Demographic Research, |
Using race- and age-specific COVID-19 case data to investigate the determinants of the excess COVID-19 mortality burden among Hispanic Americans. |
D. Phoung Do, Reanne Frank |
Ohio State University |
3 |
Epidemiology |
| 2021 May 11 |
Science Daily |
Pregnant women hospitalized for COVID-19 infection do not face increased risk of death, new study suggests |
Pregnant women have a significantly lower mortality rate compared to non-pregnant women. |
Annals of Internal Medicine |
In-Hospital Mortality in a Cohort of Hospitalized Pregnant and Nonpregnant Patients With COVID-19. |
Beth L. Pineles, et al |
University of Maryland School of Medicine |
4 |
Epidemiology |
| 2021 Apr 14 |
Indian Express |
Some children with COVID-related syndrome develop neurological symptoms |
|
JAMA |
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome |
Kerri L. LaRovere et al |
Boston Children’s Hospital, Boston, Massachusetts |
|
Epidemiology, Symptoms |
| 2021 May 03 |
Science Daily |
Applying UV light to common disinfectants makes them safer to use, study finds |
Benzalkonium chloride (BAK) is the most common active ingredient of many disinfectants used against COVID-19. It is highly toxic when used in high concentrations. Researchers found that the use of BAK followed by UVC radiation can minimize the harmful effect of BAK residues on humans and the environment. |
Cutaneous and Ocular Toxicology |
Neutralization of the eye and skin irritant benzalkonium chloride using UVC radiation. |
Manlong Xu, Jacob G. Sivak, David J. McCanna |
University of Waterloo |
4 |
General awareness |
| 2020 Nov 29 |
The Times of India |
Researchers find genetic variations linked to Covid-19 severity |
Researchers find genetic risk factors that make individuals more or less susceptible to severe Covid-19. |
The New England Journal of Medicine. |
Mining a GWAS of Severe Covid-19 |
Robert E. Gerszten et al., |
Beth Israel Deaconess Medical CenterBoston, MA |
5 |
Genetics |
| 2020 Jul 22 |
The Statesman |
Immunity drops quickly in mild COVID-19 cases, shows new study |
The researchers found a rapid drop in antibodies – the immune system proteins that help stop viruses from infecting cells in the body. |
The New England Journal of Medicine. |
|
|
University of California, Los Angeles |
5 |
Immunlogy |
| 2021 May 05 |
Science Daily |
Our immune systems blanket the SARS-CoV-2 spike protein with antibodies |
|
Science |
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes |
William N. Voss, Yixuan J. Hou, Nicole V. Johnson, George Delidakis, Jin Eyun Kim, Kamyab Javanmardi, Andrew P. Horton, Foteini Bartzoka, Chelsea J. Paresi, Yuri Tanno, Chia-Wei Chou, Shawn A. Abbasi, Whitney Pickens, Katia George, Daniel R. Boutz, Dalton M. Towers, Jonathan R. McDaniel, Daniel Billick, Jule Goike, Lori Rowe, Dhwani Batra, Jan Pohl, Justin Lee, Shivaprakash Gangappa, Suryaprakash Sambhara, Michelle Gadush, Nianshuang Wang, Maria D. Person, Brent L. Iverson, Jimmy D. Gollihar, John Dye, Andrew Herbert, Ilya J. Finkelstein, Ralph S. Baric, Jason S. McLellan, George Georgiou, Jason J. Lavinder, Gregory C. Ippolito. |
|
5 |
Immunlogy |
| 2021 May 26 |
Mint and The new Indian Express |
Mild covid-19 can induce antibodies that can last lifetime, suggests study |
|
Nature |
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans |
Ali. H Ellebedy |
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA |
5 |
Immunology |
| 2021 Apr 16 |
Science Daily |
COVID-19: Scientists identify human genes that fight infection |
Interferon genes have been identified to fight SARS-CoV-2 infection. This would help to understand the severity of the viral infection. |
Molecular Cell |
Functional Landscape of SARS-CoV-2 Cellular Restriction |
Laura Martin-Sancho et. al., |
Sanford Burnham Prebys |
4 |
Molecular biology |
| 1899 Dec 30 |
India today |
Coronavirus N protein plays critical role in viral transmission, says IISER Bhopal’s research |
|
Frontiers in cellular and infection microbiology |
SARS CoV-2 Nucleoprotein Enhances the Infectivity of Lentiviral Spike Particles (https://www.frontiersin.org/articles/10.3389/fcimb.2021.663688/full) 23 April 2021 |
Ajit Chande et al., |
Indian Institute of Science Education and Research, Bhopal, India |
5 |
Molecular interactions |
| 2021 May 04 |
The new Indian express |
Canadian researchers release first image of B.1.1.7 variant of Covid-19, exude faith in existing vaccines |
|
PLOS |
Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies |
Sriram subramanian |
|
|
Variant, structure |
| 2021 Apr 29 |
The Times of India |
Higher body weight linked with severe Covid-19 risk: Lancet study |
Obesity is a major risk factor for adverse outcomes after infection with SARS-CoV-2. The researchers aimed to examinethis association, including interactions with demographic and behavioural characteristics, type 2 diabetes, and otherhealth conditions. |
The Lancet: Diabetes and Endocrinology |
Associations between body-mass index and COVID-19 severity in 6.9 million people in England: a prospective, community-based, cohort study (published APril 28 , 2021) |
Carmen Piernas |
University of Oxford, NuffieldDepartment of Primary CareHealth Sciences, Radcliffe and other institutions Observatory Quarter, Oxford,UK |
5 |
Not sure of the category |
| 2021 Apr 29 |
Science Daily |
New cell atlas of COVID lungs reveals why SARS-CoV-2 is deadly and different |
In this study, lung autopsies of COVID-19 patients revealed a detrimental trifecta of runaway inflammation, direct destruction and impaired regeneration of lung cells involved in gas exchange, and accelerated lung scarring. The researchers gave the underlying mechanisms that cause lethality, long-term complications and showed how COVID-19 differs from other infectious diseases. |
Nature |
A molecular single-cell lung atlas of lethal COVID-19. |
Johannes C. Melms, Jana Biermann, Huachao Huang, Yiping Wang, Ajay Nair, Somnath Tagore, Igor Katsyv, Andre F. Rendeiro, Amit Dipak Amin, Denis Schapiro, Chris J. Frangieh, Adrienne M. Luoma, Aveline Filliol, Yinshan Fang, Hiranmayi Ravichandran, Mariano G. Clausi, George A. Alba, Meri Rogava, Sean W. Chen, Patricia Ho, Daniel T. Montoro, Adam E. Kornberg, Arnold S. Han, Mathieu F. Bakhoum, Niroshana Anandasabapathy, Mayte Suarez-Farinas, Samuel F. Bakhoum, Yaron Bram, Alain Borczuk, Xinzheng V. Guo, Jay H. Lefkowitch, Charles Marboe, Stephen M. Lagana, Armando Del Portillo, Emmanuel Zorn, Glen S. Markowitz, Robert F. Schwabe, Robert E. Schwartz, Olivier Elemento, Anjali Saqi, Hanina Hibshoosh, Jianwen Que, Benjamin Izar |
Columbia University Irving Medical Center |
5 |
Pathophysiology |
| 2021 Apr 30 |
Science Daily |
Novel coronavirus' spike protein plays additional key role in illness |
|
Circulation Research |
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2 |
Yuyang Lei, Jiao Zhang, Cara R. Schiavon, Ming He, Lili Chen, Hui Shen, Yichi Zhang, Qian Yin, Yoshitake Cho, Leonardo Andrade, Gerald S. Shadel, Mark Hepokoski, Ting Lei, Hongliang Wang, Jin Zhang, Jason X.-J. Yuan, Atul Malhotra, Uri Manor, Shengpeng Wang, Zu-Yi Yuan, John Y-J. Shyy. |
Salk Institute |
5 |
Pathophysiology |
| 2021 May 06 |
Science Daily |
One third of patients hospitalized with COVID-19 have lung changes after a year |
The researchers reveal that the majority of patients discharged from hospital after experiencing severe COVID-19 infection recovered to full health, although up to a third of patients' measures of lung function were still reduced. And about a quarter of patients' CT scans showed there were still small areas of change in the lungs, and this was more common in patients with more severe lung changes at the time of hospitalization. |
The Lancet Respiratory Medicine, |
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study |
Xiaojun Wu, Xiaofan Liu, Yilu Zhou, Hongying Yu, Ruiyun Li, Qingyuan Zhan, Fang Ni, Si Fang, Yang Lu, Xuhong Ding, Hailing Liu, Rob M Ewing, Mark G Jones, Yi Hu, Hanxiang Nie, Yihua Wang. |
University of Southampton |
4 |
Pathophysiology |
| 2021 May 11 |
Science Daily |
COVID-19 alters gray matter volume in the brain, new study shows |
This study showed that patients with higher levels of disability had lower gray matter volume in the superior, medial, and middle frontal gyri at discharge and six months later. Covid-19 affects the frontal-temporal network through fever or lack of oxygen. |
Neurobiology of Stress |
Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19. |
Kuaikuai Duan, Enrico Premi, Andrea Pilotto, Viviana Cristillo, Alberto Benussi, Ilenia Libri, Marcello Giunta, H. Jeremy Bockholt, Jingyu Liu, Riccardo Campora, Alessandro Pezzini, Roberto Gasparotti, Mauro Magoni, Alessandro Padovani, Vince D. Calhoun. |
Georgia Institute of Technology |
5 |
Pathophysiology |
| 2021 May 12 |
Science Daily |
The triple threat of coronavirus |
In this study, researchers revealed the mechanisms behind the quick and efficient viral replication and invasion without getting detected by the immune response. The researcher also identified the viral proteins that are involved in the process of shutting down the host machinery. |
Nature |
SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis. |
Yaara Finkel, Avi Gluck, Aharon Nachshon, Roni Winkler, Tal Fisher, Batsheva Rozman, Orel Mizrahi, Yoav Lubelsky, Binyamin Zuckerman, Boris Slobodin, Yfat Yahalom-Ronen, Hadas Tamir, Igor Ulitsky, Tomer Israely, Nir Paran, Michal Schwartz, Noam Stern-Ginossar. |
Weizmann Institute of Science |
5 |
Pathophysiology, Genes and proteins |
| 2021 May 05 |
Science Daily |
Targeted methods to control SARS-CoV-2 spread |
|
Proceedings of the Royal Society B: Biological Sciences |
Five approaches to the suppression of SARS-CoV-2 without intensive social distancing |
John M. Drake, Kyle Dahlin, Pejman Rohani, Andreas Handel. |
University of Georgia |
4 |
Preventive measures, General awareness |
| 2021 May 14 |
Science Daily |
Call for 'paradigm shift' to fight airborne spread of COVID-19 indoors |
|
Science |
A paradigm shift to combat indoor respiratory infection. |
Lidia Morawska, Joseph Allen, William Bahnfleth, Philomena M. Bluyssen, Atze Boerstra, Giorgio Buonanno, Junji Cao, Stephanie J. Dancer, Andres Floto, Francesco Franchimon, Trisha Greenhalgh, Charles Haworth, Jaap Hogeling, Christina Isaxon, Jose L. Jimenez, Jarek Kurnitski, Yuguo Li, Marcel Loomans, Guy Marks, Linsey C. Marr, Livio Mazzarella, Arsen Krikor Melikov, Shelly Miller, Donald K. Milton, William Nazaroff, Peter V. Nielsen, Catherine Noakes, Jordan Peccia, Kim Prather, Xavier Querol, Chandra Sekhar, Olli Seppanen, Shin-ichi Tanabe, Julian W. Tang, Raymond Tellier, Kwok Wai Tham, Pawel Wargocki, Aneta Wierzbicka, Maosheng Yao |
Queensland University of Technology |
3 |
Preventive measures, General awareness |
| 2021 May 04 |
Science Daily |
Researchers identify protein 'signature' of severe COVID-19 |
|
Cell Reports Medicine |
Longitudinal proteomic analysis of plasma from patients with severe COVID-19 reveal patient survival-associated signatures, tissue-specific cell death, and cell-cell interactions. |
Michael R. Filbin, Arnav Mehta, Alexis M. Schneider, Kyle R. Kays, Jamey R. Guess, Matteo Gentili, Bank G. Fenyves, Nicole C. Charland, Anna L.K. Gonye, Irena Gushterova, Hargun K. Khanna, Thomas J. LaSalle, Kendall M. Lavin-Parsons, Brendan M. Lilley, Carl L. Lodenstein, Kasidet Manakongtreecheep, Justin D. Margolin, Brenna N. McKaig, Maricarmen Rojas-Lopez, Brian C. Russo, Nihaarika Sharma, Jessica Tantivit, Molly F. Thomas, Robert E. Gerszten, Graham S. Heimberg, Paul J. Hoover, David J. Lieb, Brian Lin, Debby Ngo, Karin Pelka, Miguel Reyes, Christopher S. Smillie, Avinash Waghray, Thomas E. Wood, Amanda S. Zajac, Lori L. Jennings, Ida Grundberg, Roby P. Bhattacharyya, Blair Alden Parry, Alexandra-Chloe Villani, Moshe Sade-Feldman, Nir Hacohen, Marcia B. Goldberg |
Massachusetts General Hospital |
5 |
Proteomics |
| 2021 Apr 23 |
CNBC |
MIT researchers say you’re no safer from Covid indoors at 6 feet or 60 feet in new study challenging social distancing policies |
An MIT study showed that people who maintain 60 feet of distance from others indoors are no more protected than if they socially distanced by just 6 feet.According to the researchers, other calculations of the risk of indoor transmission have omitted too many factors to accurately quantify that risk. |
PNAS |
A guideline to limit indoor airborne transmission of COVID-19 (April 27, 2021) |
Martin Z. Bazant , John W. M. Bush |
MIT |
5 |
Public health, Transmission |
| 2021 Apr 21 |
NDTV |
SARS-CoV-2 Alters Lung Cell Metabolism IIT Kharagpur Research Model Shows |
A integrated genome-scale metabolic model of normal human bronchial epithelial cells (NHBE) infected with SARS-CoV-2 using gene-expression and macromolecular make-up of the virus was developed. This article reports a method for conducting genome-scale differential flux analysis (GS-DFA) in context-specific metabolic models. |
PLOS Computational Biology |
Genome Scale-Differential Flux Analysis reveals deregulation of lung cell metabolism on SARS-CoV-2 infection. ( April 9, 2021) |
Dr Amit Ghosh, Assistant Professor, School of Energy Science and Engineering, IIT Kharagpur.Piyush Nanda |
IIT, Kharagpur |
5 |
Research model |
| 2021 Jan 01 |
BBC |
Covid-19: New variant 'raises R number by up to 0.7' |
The new variant of Covid-19 is "hugely" more transmissible than the virus's previous version, a study has found. the new variant increases the Reproduction or R number by between 0.4 and 0.7. |
Nature |
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England (published 25 March 2021) PMID 33767447 |
Axel Gandy et al., |
The Imperial College, London |
5 |
Variant,Sequence |
| 2021 May 11 |
Science Daily |
A comprehensive map of the SARS-CoV-2 genome |
In this comparative genomics study, researchers have determined complete gene annotation of the SARS-CoV-2 genome and revealed the annotated gene set and their mutation classifications. |
Nature Communications |
SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes. |
Irwin Jungreis, Rachel Sealfon, Manolis Kellis |
Massachusetts Institute of Technology |
5 |
Sequence, Genes and Proteins |
| 2021 May 16 |
News medical |
SARS-CoV-2 Nsp2 structure revealed by cryo-EM and AI |
The structure of SARS-CoV-2 protein Nsp was predicted using CryoEM and AI methods. |
BioRxiv |
CryoEM and AI reveal a structure of SARS-CoV-2 Nsp2, a multifunctional protein involved in key host processes |
|
QBI Coronavirus Research Group Structural Biology Consortium, University of California, San Francisco, CA 94158, USA |
5 |
Structure |
| 2020 Nov 21 |
C&EN news |
Structure of SARS-CoV-2 envelope protein solved by NMR |
Crystal structure of E protein predicted by NMR |
Nature |
Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers |
Mei hong |
Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA |
5 |
Structure |
| 2021 May 04 |
Hindustan times |
Canadian experts release first molecular images of B.1.1.7 variant of Covid-19 |
The B.1.1.7 variant, first reported by the World Health Organization (WHO) in mid-December last year, has an unusually large number of mutations |
PLoS Biol |
33914735 : Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies |
Xing Zhu 1, Dhiraj Mannar 1, Shanti S Srivastava 1, Alison M Berezuk 1, Jean-Philippe Demers 1, James W Saville 1, Karoline Leopold 1, Wei Li 2, Dimiter S Dimitrov 2, Katharine S Tuttle 1, Steven Zhou , Sagar Chittori , Sriram Subramaniam |
Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada.Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh Medical School, Pittsburgh, Pennsylvania, United States of America. |
5 |
Variant,Structure, Molecular interactions |
| 2021 Apr 27 |
News Medical |
Triple mutation in SARS-CoV-2 seen in second wave of COVID-19 in India |
|
Biorxiv |
Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India (https://doi.org/10.1101/2021.04.22.440932) |
Cherian S. et al. (2021) |
CSIR-Institute of Genomics and Integrative Biology, New Delhi, ICMR-National Institute of Virology, Pune, National Centre for Disease Control, New Delhi, |
5 |
Variant,Structure, mutations, phylogentic analysis, molecular interactions |
| 2021 Apr 29 |
News 18 |
Exposure to SARS-CoV-2 Spike Protein Alone Enough to Damage Lungs: Study |
Study reveals that SARC-CoV-2 protein alone can induce Covid-19-like symptoms including severe inflammation of the lungs. |
The findings will be presented at the American Society for Pharmacology and Experimental Therapeutics annual meeting during the virtual Experimental Biology 2021 meeting, to be held April 27-30. |
|
Pavel Solopovhttps://www.linkedin.com/in/pavel-solopov-a9769412a/ |
Old Dominion University, Virginia, US |
5 |
Structure, Symptoms |
| 2021 Apr 26 |
The Statesman |
IIT-Madras studying Coronavirus’ high transmission potential |
Studying the high transmission rate and mortality of SARS-CoV-2, using computational tools. The team studied its two close variants — SARS-CoV and NL63. |
Proteins |
Why are ACE2 binding coronavirus strains SARS‐CoV/SARS‐CoV‐2 wild and NL63 mild? ( published 27 Nov 2020)33210300 |
M. Micheal Gromiha |
IIT Madras, |
5 |
Structure, Symptoms |
| 2021 Jan 27 |
-BBC |
Covid-19: Cough, fatigue, sore throat 'more common' with new variant |
Prof Lawrence Young, virologist and professor of molecular oncology at the University of Warwick, said the new variant of the virus had 23 changes compared to the original Wuhan virus. The analysis is part of a long-term study to track coronavirus in the UK population, carried out jointly with Public Health England, the University of Oxford and the University of Manchester. |
|
~ |
Prof Lawrence Young |
University of Warwick |
5 |
Variant,Symptoms |
| 2020 Nov 19 |
Science Daily |
Three reasons why COVID-19 can cause silent hypoxia |
Silent hypoxia," is a condition when oxygen levels in the body are abnormally low, which can irreparably damage vital organs if gone undetected for too long. |
Nature Communications |
Modeling lung perfusion abnormalities to explain early COVID-19 hypoxemia. |
Jacob Herrmann, Vitor Mori, Jason H. T. Bates, Bela Suki. |
Boston University |
5 |
Symptoms |
| 2021 May 12 |
Science Daily |
Fatigue, mood disorders associated with post-COVID-19 syndrome |
In this study report, researchers revealed about the post-COVID-19 syndrome. Patients diagnosed with the post-COVID-19 syndrome, experience symptoms such as mood disorders, fatigue, and perceived cognitive impairment that can negatively affect returning to work and resuming normal activities. |
Mayo Clinic Proceedings |
Post COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at the Mayo Clinic and Characteristics of the Initial Patient Cohort |
Greg Vanichkachorn, Richard Newcomb, Clayton T. Cowl, M. Hassan Murad, Laura Breeher, Sara Miller, Michael Trenary, Daniel Neveau, Steven Higgins. |
Mayo Clinic |
5 |
Symptoms |
| 2021 May 11 |
Science Daily |
Study finds 80 percent of hospitalized COVID-19 patients have neurological issues |
In this study, researchers reveal the incidence, severity, and outcomes of neurological manifestations of COVID-19 disease. |
JAMA Network Open, |
Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium |
Sherry H.-Y. Chou et al |
University of Pittsburgh |
5 |
Symptoms |
| 2021 May 03 |
Science Daily |
Speeding new treatments |
The researchers developed REDIAL-2020, an open-source online tool that rapidly screens small molecules for their potential COVID-fighting properties. |
Nature Machine Intelligence |
A machine learning platform to estimate anti-SARS-CoV-2 activities. |
Govinda B. KC, Giovanni Bocci, Srijan Verma, Md Mahmudulla Hassan, Jayme Holmes, Jeremy J. Yang, Suman Sirimulla, Tudor I. Oprea |
University of New Mexico Health Sciences Center |
5 |
Tool (for COVID drug repurposing ) |
| 2021 Apr 03 |
The Indian Express |
New research: Low risk of scientists passing coronavirus to bats in winter |
Zoonotic transmission of SARS-CoV-2 from humans to bats is studied and found that the risk of transmission can be reduced from 65% to 88% by the use of facemasks with high filtration efficiency. |
Conservation Science and Practice |
Risks posed by SARS‐CoV‐2 to North American bats during winter fieldwork |
Jonathan D. Cook, Evan H. C. Grant, Jeremy T. H. Coleman, Jonathan M. Sleeman, Michael C. Runge |
US Geological Survey (USGS) |
4 |
Transmission |
| 2021 Apr 16 |
Business Standard |
Study sheds light on ten reasons why the coronavirus is airborne: Lancet |
Asymptomatic or presymptomatic transmission of SARS-CoV-2 accout for 40% of all transmissions. According to the researchers airborne mode of transmission is an important way for the spread of COVID-19 around the world. |
Lancet |
Ten scientific reasons in support of airborne transmission of SARS-CoV-2 |
Trisha GreenhalghJose L JimenezKimberly A PratherZeynep TufekciDavid FismanRobert Schooley |
University of Oxford |
5 |
Transmission |
| 2020 Apr 13 |
Science Daily |
Study finds remdesivir effective against a key enzyme of coronavirus that causes COVID-19 |
Remdesivir has found to be effective in the inhibition of SARS-CoV-2 replication. |
Journal of Biological Chemistry. |
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. |
Calvin J Gordon, Egor P Tchesnokov, Emma Woolner, Jason K Perry, Joy Y. Feng, Danielle P Porter, Matthias Gotte. |
University of Alberta Faculty of Medicine & Dentistry |
5 |
Treatment |
| 2021 Apr 19 |
Science Daily |
Multivitamins, omega-3, probiotics, vitamin D may lessen risk of positive COVID-19 test |
|
BMJ Nutrition, Prevention & Health, |
Modest effects of dietary supplements during the COVID-19 pandemic: insights from 445 850 users of the COVID-19 Symptom Study app |
Panayiotis Louca, Benjamin Murray, Kerstin Klaser, Mark S Graham, Mohsen Mazidi, Emily R Leeming, Ellen Thompson, Ruth Bowyer, David A Drew, Long H Nguyen, Jordi Merino, Maria Gomez, Olatz Mompeo, Ricardo Costeira, Carole H Sudre, Rachel Gibson, Claire J Steves, Jonathan Wolf, Paul W Franks, Sebastien Ourselin, Andrew T Chan, Sarah E Berry, Ana M Valdes, Philip C Calder, Tim D Spector, Cristina Menni |
|
4 |
Treatment, General awareness |
| 2021 Apr 21 |
The Statesmen |
UK variant ‘45% more contagious’ than original virus |
The study, led by researchers from the Tel Aviv University in Israel, used a kit that tests for three different viral genes. In the British variant, one of these genes — the S gene — was erased by the mutation. |
Cell reports medicine |
BNT162b2 vaccination effectively prevents the rapid rise of SARS-CoV-2 variant B.1.1.7 in high-risk populations in Israel |
Ariel Muntiz, Motti Gerlic |
Tel Aviv University |
4 |
Variant,Vaccination, Epidemiology |
| 2020 Dec 31 |
The Times of India |
Moderna Covid-19 vaccine shows 94.1 per cent efficacy in trial: Study |
Efficacy of the Moderna vaccine in preventing symptomatic infection and serious illness |
The New England Journal of Medicine. |
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine (published 4th Feb 2021) |
Lindsey R. Baden et al., |
Brigham and Women's Hospital in the US( where the trial took place ) |
5 |
vaccine |
| 2021 Apr 28 |
India today |
Sputnik V arrives on May 1. What makes it different? |
Russian Covid-19 vaccine Sputnik V, with 91.6 per cent efficacy, will be available in India from May. While there was scepticism over Sputnik V as Russia had not shared its trial data, perceptions changed when the trial data published in The Lancet said the vaccine "appears safe and effective". |
The Lancet |
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia (published 20 feb, 2021) |
Denis Y Logunov, et al., |
National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya” of the Ministry of Health of the Russian Federation, Moscow 123098, Russia |
5 |
Vaccine |
| 2021 Nov 05 |
India today |
Bharat Biotech’s Covid-19 vaccine could be launched by February, says ICMR scientist |
Bharat Biotech, a private company that is developing Covaxin with the government-run Indian Council of Medical Research (ICMR), had earlier said it hoped to launch the vaccine only in the second quarter of next year. |
The Lancet Infectious Diseases |
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial ( 8 March 2021 |
Raches Ella, Siddharth Reddy, Harsh Jogdand, Vamshi Sarangi, Brunda Ganneru, Sai Prasad, Dipankar Das, Dugyala Raju, Usha Praturi, Gajanan Sapkal, Pragya Yadav, Prabhakar Reddy, Savita Verma, Chandramani Singh, Sagar Vivek Redkar, Chandra Sekhar Gillurkar, Jitendra Singh Kushwaha, Satyajit Mohapatra, Amit Bhate, Sanjay Rai, Samiran Panda, Priya Abraham, Nivedita Gupta, Krishna Ella, Balram Bhargava, Krishna Mohan Vadrevu |
Bharat Biotech |
5 |
Vaccines |
| 2021 Apr 28 |
Science Daily |
Only one in four people experience mild systemic side effects from COVID-19 vaccines, study finds |
|
he Lancet Infectious Diseases |
Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study |
Cristina Menni, Kerstin Klaser, Anna May, Lorenzo Polidori, Joan Capdevila, Panayiotis Louca, Carole H Sudre, Long H Nguyen, David A Drew, Jordi Merino, Christina Hu, Somesh Selvachandran, Michela Antonelli, Benjamin Murray, Liane S Canas, Erika Molteni, Mark S Graham, Marc Modat, Amit D Joshi, Massimo Mangino, Alexander Hammers, Anna L Goodman, Andrew T Chan, Jonathan Wolf, Claire J Steves, Ana M Valdes, Sebastien Ourselin, Tim D Spector. |
King's College London |
5 |
Vaccines |
| 2021 May 11 |
Science Daily |
COVID-19 vaccine does not damage the placenta in pregnancy |
In this research study, it is found that Moderna or Pfizer vaccines are safe in pregnancy. No vaccines related injury was found in pregnant women. |
Obstetrics & Gynecology |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination in Pregnancy. |
Elisheva D. Shanes, Sebastian Otero, Leena B. Mithal, Chiedza A. Mupanomunda, Emily S. Miller, Jeffery A. Goldstein. |
Northwestern University |
5 |
Vaccines |
| 2021 May 06 |
Science Daily |
COVID-19 vaccine is associated with fewer asymptomatic SARS-CoV-2 infections, study finds |
|
JAMA |
Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce. |
Li Tang, Diego R. Hijano, Aditya H. Gaur, Terrence L. Geiger, Ellis J. Neufeld, James M. Hoffman, Randall T. Hayden. |
St. Jude Children's Research Hospital |
4 |
Vaccines |
| 2021 May 12 |
Science Daily |
Delaying second COVID vaccine dose may prevent deaths under certain conditions |
In this study, researchers revealed that delay in the second dose of vaccine can decrease cumulative mortality, infections, and hospital admissions rate. |
BMJ Nutrition, Prevention & Health, |
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study. |
Santiago Romero-Brufau, Ayush Chopra, Alex J Ryu, Esma Gel, Ramesh Raskar, Walter Kremers, Karen S Anderson, Jayakumar Subramanian, Balaji Krishnamurthy, Abhishek Singh, Kalyan Pasupathy, Yue Dong, John C O’Horo, Walter R Wilson, Oscar Mitchell, Thomas C Kingsley. |
BMJ |
4 |
Vaccines, Epidemiology |
| 2021 May 13 |
Science Daily |
COVID-19 mRNA vaccines are immunogenic in pregnant and lactating women, study finds |
In this study, researchers found that Pfizer or Moderna vaccines triggered immune responses in pregnant and lactating women. The vaccine-elicited antibodies were detected in both infant cord blood and breast milk. Thus, suggesting that vaccinating pregnant mothers may potentially protect infants from COVID-19 infection. It was also found that both pregnant and non-pregnant women developed cross-reactive immune responses against the COVID-19 variants of concern B.1.1.7 and B.1.351. |
JAMA |
Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women. |
Ai-ris Y. Collier, Katherine McMahan, Jingyou Yu, Lisa H. Tostanoski, Ricardo Aguayo, Jessica Ansel, Abishek Chandrashekar, Shivani Patel, Esther Apraku Bondzie, Daniel Sellers, Julia Barrett, Owen Sanborn, Huahua Wan, Aiquan Chang, Tochi Anioke, Joseph Nkolola, Connor Bradshaw, Catherine Jacob-Dolan, Jared Feldman, Makda Gebre, Erica N. Borducchi, Jinyan Liu, Aaron G. Schmidt, Todd Suscovich, Caitlyn Linde, Galit Alter, Michele R. Hacker, Dan H. Barouch. |
Beth Israel Deaconess Medical Center. |
5 |
Vaccines, immunology |
| 2021 May 10 |
Science Daily |
New vaccine blocks COVID-19 and variants, plus other coronaviruses |
|
Nature |
Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses. |
Kevin O. Saunders, et al |
Duke University Medical Center |
5 |
Vaccines, Immunology |
| 2021 May 10 |
Science Daily |
The 'key' to new COVID-19 vaccine development |
|
Frontiers in Immunology, |
A Structural Landscape of Neutralizing Antibodies Against SARS-CoV-2 Receptor Binding Domain. |
Ling Niu, Kathryn N. Wittrock, Gage C. Clabaugh, Vikram Srivastava, Michael W. Cho |
Iowa State University |
5 |
Vaccines, Immunology |
| 2021 May 02 |
News Medical |
Previously infected vaccinees broadly neutralize SARS-CoV-2 variants of concern |
|
Medrixv |
Previously infected vaccinees broadly neutralize SARS-CoV-2 variants |
Hans C. Leier et al., |
Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Division of Infectious Diseases, Oregon Health & Science University |
5 |
Vaccines, immunology, variants |
| 2021 May 07 |
News Medical |
Pfizer-BioNTech mRNA vaccine reduces both symptomatic and asymptomatic COVID-19 infection in case study |
|
JAMA |
Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce.(https://doi.org/10.1001/jama.2021.6564) |
Tang, L et al., |
|
5 |
Vaccines, symptoms |
| 2021 May 08 |
News Medical |
Increased heart rate as a physiological response to SARS-CoV-2 mRNA vaccine |
|
medRxiv 2021, doi: https://doi.org/10.1101/2021.05.03.21256482 |
The Physiologic Response to COVID-19 Vaccination. |
Quer G., et al. |
Scripps Research Translational Institute in California, USA, |
5 |
Vaccines, Symptoms |
| 2021 Apr 22 |
The NewYork Times |
Vaccines Are Effective Against the New York Variant, Studies Find |
|
Biorxiv (https://www.biorxiv.org/content/10.1101/2021.02.14.431043v3) |
Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York |
Anthony P. West Jr et al |
Rockefeller University , New York |
|
Vaccines, Variants |
| 2021 Feb 22 |
NDTV |
COVID-19 Variant N440K Spreading More In Southern States: Centre For Cellular And Molecular Biology |
Scientists from Centre for Cellular and Molecular Biology, in a recent publication, have presented an exhaustive analysis of over 5,000 coronavirus variants in India and how they have evolved over the course of the pandemic |
Biorxiv |
N440K variant of SARS-CoV-2 has Higher Infectious Fitness ( https://www.biorxiv.org/content/10.1101/2021.04.30.441434v1.full.pdf) |
Dixit Tandel, Divya Gupta, Vishal Sah, Krishnan Harinivas Harshan |
CCMB, Hyderabad |
5 |
Variant |
| 2021 May 03 |
The scientist |
What Scientists Know About the B.1.617 Coronavirus Variant |
More insight into new variant/double mutant B.1.617 Coronavirus Variant. |
Biorxiv |
Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees |
Pragya D.yadhav |
ICMR-NIV, Pune |
5 |
Variant |
| 1899 Dec 30 |
|
CDC recommends pregnant women get Covid vaccine after study shows it’s safe for mother and baby |
|
|
|
Tom T. Shimabukuro |
|
|
|
| 2021 May 28 |
Science Daily |
Researchers discover drug that blocks multiple SARS-CoV-2 variants in mice |
|
Science Immunology, |
Pharmacological activation of STING blocks SARS-CoV-2 infection. |
Minghua Li, Max Ferretti, Baoling Ying, Helene Descamps, Emily Lee, Mark Dittmar, Jae Seung Lee, Kanupriya Whig, Brinda Kamalia, Lenka Dohnalova, Giulia Uhr, Hoda Zarkoob, Yu-Chi Chen, Holly Ramage, Marc Ferrer, Kristen Lynch, David C. Schultz, Christoph A. Thaiss, Michael S. Diamond, Sara Cherry |
University of Pennsylvania School of Medicine |
5 |
Drugs, Animal Studies |
| 2021 May 28 |
Science Daily |
Helping doctors manage COVID-19 |
|
Scientific Reports, |
Towards computer-aided severity assessment via deep neural networks for geographic and opacity extent scoring of SARS-CoV-2 chest X-rays. |
A. Wong, Z. Q. Lin, L. Wang, A. G. Chung, B. Shen, A. Abbasi, M. Hoshmand-Kochi, T. Q. Duong |
University of Waterloo |
5 |
Diagnostics |
| 2021 May 26 |
Science Daily |
Inhaled nanobodies protect hamsters from COVID-19, study finds |
|
Science Advances, |
Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses. |
|
University of Pittsburgh |
5 |
Drugs, Animal Studies |
| 2021 May 26 |
Science Daily |
Ultrasensitive blood test detects viral protein, confirms mRNA vaccine activates robust immune response |
|
Clinical Infectious Diseases, |
Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients. |
Alana F Ogata, Chi-An Cheng, Michael Desjardins, Yasmeen Senussi, Amy C Sherman, Megan Powell, Lewis Novack, Salena Von, Xiaofang Li, Lindsey R Baden, David R Walt |
Brigham and Women's Hospital |
5 |
Vaccines |
| 2021 May 25 |
Science Daily |
Harnessing next generation sequencing to detect SARS-CoV-2 and prepare for the next pandemic |
|
Nature Communications, |
Multiplexed detection of SARS-CoV-2 and other respiratory infections in high throughput by SARSeq. |
Ramesh Yelagandula, Aleksandr Bykov, Alexander Vogt, Robert Heinen, Ezgi Ozkan, Marcus Martin Strobl, Juliane Christina Baar, Kristina Uzunova, Bence Hajdusits, Darja Kordic, Erna Suljic, Amina Kurtovic-Kozaric, Sebija Izetbegovic, Justine Schaeffer, Peter Hufnagl, Alexander Zoufaly, Tamara Seitz, Manuela Fodinger, Franz Allerberger, Alexander Stark, Luisa Cochella, Ulrich Elling |
IMBA- Institute of Molecular Biotechnology of the Austrian Academy of Sciences |
5 |
Diagnostics |
| 2021 May 25 |
Science Daily |
A COVID-fighter's guide to T cells |
|
Cell Host & Microbe |
SARS-CoV-2 Human T cell Epitopes: adaptive immune response against COVID-19. |
Alba Grifoni, John Sidney, Randi Vita, Bjoern Peters, Shane Crotty, Daniela Weiskopf, Alessandro Sette. |
La Jolla Institute for Immunology |
5 |
Immunology |